From Reuters.

Novo Nordisk shares jumped more than 8% after Hims & Hers abandoned the launch of their $49 weight-loss pill. The company withdrew the product following legal threats from Novo Nordisk and the FDA

#weightloss # semaglutide #ozempic #wegovy #news #Reuters #Newsfeed

Read the story here: https://reut.rs/4rpq34p

👉 Subscribe: http://smarturl.it/reuterssubsclatest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en